Concepedia

Saravanan Balamuthusamy

SB

16

Publications

761

Citations

12

H-Index

2006

Active since

Affiliations

Tulane University(Current)

Tarrant County College

The George Institute for Global Health

Texas Research Institute

Concord Repatriation General Hospital

Saravanan Balamuthusamy is an author at Tulane University specializing in medicine, chronic kidney disease, and nephrology.

ORCID

Top concepts

Publications per year

2006–2023

16

Publications

16

Efficacy and safety of sparsentan versus irbesartan in patients with IgA nephropathy (PROTECT): 2-year results from a randomised, active-controlled, phase 3 trial

Brad H. Rovin, Jonathan Barratt, Hiddo J.L. Heerspink et al. · The Lancet · 2023 · 224 citations · Full text

Sparsentan in patients with IgA nephropathy: a prespecified interim analysis from a randomised, double-blind, active-controlled clinical trial

Hiddo J.L. Heerspink, Jai Radhakrishnan, Charles E. Alpers et al. · The Lancet · 2023 · 203 citations · Full text

, , +9

Silencing megalin and cubilin genes inhibits myeloma light chain endocytosis and ameliorates toxicity in human renal proximal tubule epithelial cells

Min Li, Saravanan Balamuthusamy, Eric E. Simon et al. · American Journal of Physiology-Renal Physiology · 2008 · 72 citations

, , +16

Circulating Adipocytokines and Chronic Kidney Disease

Katherine T. Mills, L. Lee Hamm, Arnold Alper et al. · PLoS ONE · 2013 · 42 citations · Full text

Pituitary adenylate cyclase-activating polypeptide ameliorates cisplatin-induced acute kidney injury

Min Li, Saravanan Balamuthusamy, Altaf M. Khan et al. · Peptides · 2009 · 28 citations

, , +4

Rows per page

1–5 of 16